baylor_college_of_medicine_publications

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revision Previous revision
Last revision Both sides next revision
baylor_college_of_medicine_publications [2021/04/22 09:06]
administrador
baylor_college_of_medicine_publications [2021/05/09 10:20]
administrador
Line 594: Line 594:
  
 90: Soomro Z, Youssef M, Yust-Katz S, Jalali A, Patel AJ, Mandel J. 90: Soomro Z, Youssef M, Yust-Katz S, Jalali A, Patel AJ, Mandel J.
-Paraneoplastic syndromes in small cell lung cancer. J Thorac Dis. 2020+Paraneoplastic syndromes in Small-cell lung cancer. J Thorac Dis. 2020
 Oct;12(10):6253-6263. doi: 10.21037/jtd.2020.03.88. PMID: 33209464; PMCID: Oct;12(10):6253-6263. doi: 10.21037/jtd.2020.03.88. PMID: 33209464; PMCID:
 PMC7656388. PMC7656388.
Line 2347: Line 2347:
 Hwu P, Heymach JV, Sharma P, Allison JP, Baladandayuthapani V, Lee JJ, Davis MM, Hwu P, Heymach JV, Sharma P, Allison JP, Baladandayuthapani V, Lee JJ, Davis MM,
 Wistuba II, Futreal PA, Zhang J. Comprehensive T cell repertoire Wistuba II, Futreal PA, Zhang J. Comprehensive T cell repertoire
-characterization of non-small cell lung cancer. Nat Commun. 2020 Jan+characterization of non-Small-cell lung cancer. Nat Commun. 2020 Jan
 30;11(1):603. doi: 10.1038/s41467-019-14273-0. PMID: 32001676; PMCID: 30;11(1):603. doi: 10.1038/s41467-019-14273-0. PMID: 32001676; PMCID:
 PMC6992630. PMC6992630.
Line 2365: Line 2365:
 370: Chun SG, Liao Z, Jeter MD, Chang JY, Lin SH, Komaki RU, Guerrero TM, Mayo 370: Chun SG, Liao Z, Jeter MD, Chang JY, Lin SH, Komaki RU, Guerrero TM, Mayo
 RC, Korah BM, Koshy SM, Heymach JV, Koong AC, Skinner HD. Metabolic Responses to RC, Korah BM, Koshy SM, Heymach JV, Koong AC, Skinner HD. Metabolic Responses to
-Metformin in Inoperable Early-stage Non-Small Cell Lung Cancer Treated With+Metformin in Inoperable Early-stage Non-Small-cell lung cancer Treated With
 Stereotactic Radiotherapy: Results of a Randomized Phase II Clinical Trial. Am J Stereotactic Radiotherapy: Results of a Randomized Phase II Clinical Trial. Am J
 Clin Oncol. 2020 Apr;43(4):231-235. doi: 10.1097/COC.0000000000000632. PMID: Clin Oncol. 2020 Apr;43(4):231-235. doi: 10.1097/COC.0000000000000632. PMID:
Line 7306: Line 7306:
 Stahl JM, Daly ME, Decker RH, Hales RK, Willers H, Videtic GM, Mehta MP, Lin SH. Stahl JM, Daly ME, Decker RH, Hales RK, Willers H, Videtic GM, Mehta MP, Lin SH.
 Multi-Institutional Experience of Stereotactic Ablative Radiation Therapy for Multi-Institutional Experience of Stereotactic Ablative Radiation Therapy for
-Stage I Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys. 2017 Feb+Stage I Small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2017 Feb
 1;97(2):362-371. doi: 10.1016/j.ijrobp.2016.10.041. Epub 2016 Nov 2. PMID: 1;97(2):362-371. doi: 10.1016/j.ijrobp.2016.10.041. Epub 2016 Nov 2. PMID:
 28011047. 28011047.
Line 8831: Line 8831:
  
 1360: Haque W, Szeja S, Tann A, Kalra S, Teh BS. Changes in Treatment Patterns 1360: Haque W, Szeja S, Tann A, Kalra S, Teh BS. Changes in Treatment Patterns
-and Overall Survival in Patients With Early-Stage Non-Small Cell Lung Cancer in+and Overall Survival in Patients With Early-Stage Non-Small-cell lung cancer in
 the United States After the Incorporation of Stereotactic Ablative Radiation the United States After the Incorporation of Stereotactic Ablative Radiation
 Therapy: A Population-based Analysis. Am J Clin Oncol. 2018 Mar;41(3):259-266. Therapy: A Population-based Analysis. Am J Clin Oncol. 2018 Mar;41(3):259-266.
Line 10347: Line 10347:
 1611: Hoa NT, Ge L, Tajhya RB, Beeton C, Cornforth AN, Abolhoda A, Lambrecht N, 1611: Hoa NT, Ge L, Tajhya RB, Beeton C, Cornforth AN, Abolhoda A, Lambrecht N,
 DaCosta-Iyer M, Ouyang Y, Mai AP, Hong E, Shon J, Hickey MJ, Erickson KL, Kruse DaCosta-Iyer M, Ouyang Y, Mai AP, Hong E, Shon J, Hickey MJ, Erickson KL, Kruse
-CA, Jadus MR. Small cell lung cancer cells express the late stage gBK tumor+CA, Jadus MR. Small-cell lung cancer cells express the late stage gBK tumor
 antigen: a possible immunotarget for the terminal disease. Am J Transl Res. 2014 antigen: a possible immunotarget for the terminal disease. Am J Transl Res. 2014
 May 15;6(3):188-205. PMID: 24936214; PMCID: PMC4058303. May 15;6(3):188-205. PMID: 24936214; PMCID: PMC4058303.
Line 11196: Line 11196:
  
 1778: Fridley J, Adams G, Rao V, Patel A, Humphries W, Goodman C, Gopinath S. 1778: Fridley J, Adams G, Rao V, Patel A, Humphries W, Goodman C, Gopinath S.
-Small cell lung cancer metastasis in the pituitary gland presenting with+Small-cell lung cancer metastasis in the pituitary gland presenting with
 seizures and headache. J Clin Neurosci. 2011 Mar;18(3):420-2. doi: seizures and headache. J Clin Neurosci. 2011 Mar;18(3):420-2. doi:
 10.1016/j.jocn.2010.05.006. Epub 2011 Jan 14. PMID: 21237653. 10.1016/j.jocn.2010.05.006. Epub 2011 Jan 14. PMID: 21237653.
  • baylor_college_of_medicine_publications.txt
  • Last modified: 2021/05/20 18:56
  • by administrador